Skip to main content

Aqua Bio Technology ASA: 2018 accounts to be restated

Reference is made to Aqua Bio Technology ASA’s (ABT) stock exchange release dated 21 January, 2020, regarding notice of decision by the Financial Supervisory Authority of Norway (Finanstilsynet). In its notice, Finanstilsynet advised ABT that it did not find the stated value of the inventory of skin care product ingredients sufficiently substantiated, and therefore considered instructing the Company to write down the inventory to NOK 0. In its notice Finanstilsynet also concluded that since Restorsea does not have a legal obligation to exercise its options to extend its exclusivity from 2022 to 2027 and from 2027 to 2032, against payment of MUSD 2.5 for each extension, such future payments cannot be taken into consideration when estimating net realization value of ABT’s inventory for Restorsea.  Furthermore, Finanstilsynet advised ABT that an estimate of the recoverable amount of ABT’s patents should have been made at the end of 2018 based on these assumptions, and that it considered instructing the Company to do so.ABT still believes that Restorsea will succeed with its commercialization strategy and therefore will exercise its options to extend its exclusivity with further exclusivity payments to ABT, which implies that ABT’s inventory has a substantial value. After having reviewed Finanstilsynet’s conclusions, ABT’s board of directors has resolved to restate the Company’s 2018 accounts. The inventory of skin care product ingredients as well as the carrying amount of patents are being written down to NOK 0 as of 31 December, 2018. The combined impairment amounts to NOK 20,105,942.Consequently, the restated 2018 financial result for ABT is NOK -38,466,070, whereas the previously reported financial result was NOK -18,360,128. Furthermore, the Company’s equity as of 31 December, 2018, is being restated to NOK -197,159. The previously reported equity at the end of 2018 was NOK 19,908,783. All corrections have been made in accordance with International Accounting Standards (IAS) 8 and will be reflected in the 2019 financial statements.ABT’s board of directors has reviewed Finanstilsynet’s notice. It is the board’s opinion that the value of the inventory and the patents are closely interlinked. Following Finanstilsynet’s advice, the board has therefore resolved to value both the inventory and the patents at NOK 0 as of 31 December 2018.For further information, please contact Mr Edvard Cock, Chairman of the Board, telephone +47 415 04 004. 

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.